APPLIED BIOSYSTEMS EXPANDS WORK WITH UM

A California company said it has expanded its collaboration with the University of Miami and Stanford University to study genetic biomarkers associated with treatment response and survival in the most common form of non-Hodgkin's lymphoma. Foster City-based Applied Biosystems said its studies are of diffuse large B cell lymphoma (DLBCL).

South Florida Business Journal (http://www.bizjournals.com/southflorida/stories/2005/01/10/daily8.html)